We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Rua Life Sciences Plc | LSE:RUA | London | Ordinary Share | GB0033360586 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.25 | 2.25% | 11.375 | 10.75 | 12.00 | 11.375 | 11.125 | 11.13 | 90,931 | 08:24:24 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Plastics,resins,elastomers | 2.18M | -2M | -0.0323 | -3.52 | 7.06M |
Date | Subject | Author | Discuss |
---|---|---|---|
28/9/2021 13:41 | interested in what looks like a large tam vs the market cap with inflection points coming up. Small caps can always go wrong but it reminds me of Maxcyte in some ways back when it was undiscovered. Would you agree with that? | nimbo1 | |
28/9/2021 13:33 | agreed parsons - a very illiquid share so an inelastic share price reaction to buys and sells | herschel k | |
28/9/2021 13:26 | These are very tightly held, any reasonable buying has a big effect on the price, good luck as the broker has a much higher target value for the shares. | parsons4 | |
28/9/2021 12:58 | have started buying here... price reacting annoyingly, hope it comes down again. | nimbo1 | |
27/9/2021 09:24 | 100% agree with that, SV. | bones | |
27/9/2021 08:49 | I don’t know why the holding notices are written in code rather than plain English? | semper vigilans | |
27/9/2021 08:47 | Thanks Langland. Actually, having looked back at the earlier holdings RNS’s, there was one on 4th January 2021 from WC declaring 8.65% after the placing took effect, so I am a bit confused why RUA published 13.21% as at 5th January! | bones | |
27/9/2021 08:21 | WC is one of the brokers I use and I know they do everything to the letter so I guess we should draw our own conclusions. | langland | |
27/9/2021 08:07 | Based on today’s holdings RNS, clients of Walker Crips have sold nearly 2 million shares in RUA since the start of 2021 (using the disclosure in RUA’s website dated 5th January 2021). Given we have had no disclosures from WC as the reductions passed each 1% threshold, it doesn’t say much for the adherence to the rules. Alternatively, a large 9% bloc has only just been transferred to someone yet to disclose! | bones | |
17/9/2021 12:32 | Absolutely, not to be bandied around. Clearly a lot of confidence in the product and where it can go. More buyers and the market are waking up ! gla | andyview | |
17/9/2021 12:16 | Agreed, the use of the words "potentially seminal" would not have been chosen lightly. Very interesting times ahead. | sicilian_kan | |
17/9/2021 11:23 | EACTS meeting is 13 - 16 October. Not long to wait for "potentially seminal" moment. Hope the 510K submission has been announced before.... | unionhall | |
17/9/2021 11:12 | Yes Landy, very important points underwriting the game changing potential. I particularly like the comment: "We remain on target to launch the world's first non-biogenically sealed grafts by the end of this financial year." Suggests that the value of Elasteon, as the go to disruptive sealant tech enabler, is about to rerate. And once you convert to non-biogenic, why go back? | greedy rooster | |
17/9/2021 09:20 | Thinking a little more, if leakage is better, that would have a big impact on chest drainage. The average time on a chest drain for this procedure is 2 to 3 day. Reducing that time by even a day gets the patient up and walking sooner , promotes faster healing and if it gets them out of hospital sooner cuts costs. | landy90 | |
17/9/2021 08:52 | Bones, good point as ever, seminal is pretty powerful. The invivo testing would have been carried out to demonstrate the graft was equivalent to contro grafts as required by 510k requirements. My reading of this is that there were observations from the animal trials that point to significant clinical benefits. Once launched, the surgeons will look to undertake studies to demonstrate these clinical benefits which ultimately result in a shift away from the old fashioned animal sealant. Benefits could be less inflammation/infecti | landy90 | |
17/9/2021 08:50 | Not sure the market has given full recognition of the news here...perhaps as the day progresses we will see more ... gla | andyview | |
17/9/2021 08:49 | Agree, bones, 'seminal' is the keyword. | langland | |
17/9/2021 08:05 | You don’t often see the word “seminal” ”RUA is very excited by the observations from the 'in vivo' testing and believes this could become a potentially seminal paper on the future direction of surgical graft implantation.” There must be some confidence in this expressed by important people in the industry. | bones | |
17/9/2021 08:03 | managed to pick a few more up this morning... gla | andyview | |
17/9/2021 08:00 | Its great news | andyview | |
17/9/2021 07:57 | Successful In Vivo test???!!! Is this expected? | toffeeman | |
17/9/2021 07:41 | A very welcome update albeit almost a given. Delivered on a Friday, does RUA not know the general AIM market rule. | cocker |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions